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ABSTRACT
Telomeres are known to prevent chromosome ends
from being recognized as DNA double-strand
breaks. Conversely, many DNA damage response
proteins, including ATM, are thought to participate
to telomere maintenance. However, the precise
roles of ATM at telomeres remain unclear due to
its multiple functions in cell checkpoints and
apoptosis. To gain more insights into the role of
ATM in telomere maintenance, we determined the
effects of the G-quadruplex ligand 360A in various
cell lines lacking functional ATM. We showed, by
using Fluorescence in situ hybridization (FISH) and
Chromosome Orientation-FISH using telomere PNA
probes, that 360A induced specific telomere aberra-
tions occurring during or after replication, mainly
consisting in sister telomere fusions and also
recombinations that involved preferentially the lag-
ging strand telomeres. We demonstrate that ATM
reduced telomere instability independently of apop-
tosis induction. Our results suggest thus that ATM
has a direct role in preventing inappropriate DNA
repair at telomeres, which could be related to its
possible participation to the formation of protected
structures at telomeres.
INTRODUCTION
Human telomeric DNA contains double-stranded repeats
of the motif TTAGGG followed by a G-rich 30-overhang
and is capped by a speciﬁc telomere multiprotein complex
referred to as shelterin (1). Telomeres can adopt a
protective T-loop structure in which the telomeric
30-overhang is incorporated into the proximal double-
stranded telomeres (2). T-loop has been proposed to
prevent telomeres from being recognized as DNA double-
strand breaks (DSBs) and thus from activating cell cycle
checkpoints, inappropriate DNA repair and cell death.
The ATM (ataxia telangiectasia mutated) gene product
is involved in the rare disease ataxia-telangectasia (AT)
characterized by progressive cerebellar degeneration,
immunodeﬁciency and cancer predisposition. AT cells
exhibit abnormalities including defects in cell cycle
checkpoints, increased radiation sensitivity and chromo-
some instability. ATM belongs to the phosphoinositol
3-kinase family and plays crucial roles in cellular response
to DNA damage (3–5). ATM is principally activated
following DNA DSBs throughout the cell cycle by
autophosphorylation of its residue serine 1981 (6,7) and
leads to the phosphorylation of multiple downstream
proteins principally involved in DNA damage recognition,
cell cycle checkpoints and apoptosis (8), such as p53,
H2AX, CHK2 and SMC1.
ATM has been reported to be the main transducer of
the telomere damage signal due to telomere attrition
during senescence or TRF2 (telomeric repeat factor 2)
inhibition (9,10). TRF2 was reported to be a speciﬁc
inhibitor of ATM on telomeres (9–11). It has been
demonstrated that mutations in ATM lead to defective
telomere maintenance in mammalian cells (3). Indeed,
AT cells show increase chromosome end-to-end associa-
tion and telomere loss. Particularly AT cells are more
prone to telomere fusion after irradiation than normal
cells (3,12,13). ATM inﬂuences the interactions between
telomeres and the nuclear matrix, and alterations in
telomere chromatin could be at least partly responsible for
the pleiotropic phenotypes of the ATM gene defect (14).
This is illustrated by the accumulation of cells with
clustered telomeres during meiosis in ATM null cells,
which account for infertility (15). Recent reports have also
shown that ATM was recruited at telomeres in G2 phase
of the cell cycle and it has been suggested that telomere
ends need to be recognized as DNA damage to complete
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for function (16–18). However, the exact roles of ATM
at telomeres remained largely unclear due to its multiple
functions. It is particularly diﬃcult to discern a possible
role in telomere replication from its role at dysfunctional
telomeres and in induction of cell checkpoints
and apoptosis.
Structure studies (X-ray crystallography and nuclear
magnetic resonance) of oligonucleotides have indicated
that the telomeric-30-overhang could adopt a variety of
quadruplex structures based on four Hoogsteen-paired,
coplanar guanines (19–21), referred to as G-quadruplex.
Various G-quadruplex ligands have been described to
have antiproliferative eﬀects toward cancer cells (22,23).
We have previously identiﬁed a highly selective G-
quadruplex ligand 360A (24), a 2,6-pyridine-dicarboxylate
derivative that can bind to human chromosome end in vivo
(25) and provokes telomere instability and apoptosis in
immortalized cell lines (24).
Here, we compare the eﬀects of the G-quadruplex
ligand 360A on various ATM-deﬁcient or knocked-down
cells lines. We provide evidences that ATM has a
direct role in preventing inappropriate DNA repair at
dysfunctional telomeres independently of cell cycle
checkpoint and apoptosis induction.
MATERIALS AND METHODS
Chemical compounds
360A is a 2,6-pyridine-dicarboxamide derivative display-
ing strong aﬃnity and selectivity for G-quadruplex
structures and selective telomerase inhibition in in vitro
assays (24). 360A was dissolved at 10mM in dimethyl
sulfoxide (DMSO), stored at –208C and diluted with
culture medium immediately before use.
Cellculture
Stable knockdown HeLa clones for ATM gene (ATM
KD)
expressing small interfering RNA (siRNA) have been
previously described [(26,27) and Supplementary
Figure 1). As control, we used a stable HeLa clone
transfected with a control EBV vector (pBD650) (26).
HeLa clones (1 10
6 cells/ﬂask) were cultured in DMEM
medium supplemented with 10% Fetal Bovine Serum
(FBS, ATGC), 2mM glutamine, antibiotics (penicillin,
200U/ml and streptomycin, 200mg/ml, Sigma), 1mM
HEPES (Invitrogen) and 250mg/ml hygromycin B
(Invitrogen). Simian virus 40 (SV40)-transformed human
normal ﬁbroblast (AS3WT2) (28) and SV40-transformed
AT ﬁbroblast (GM09607) cell lines (1 10
6cells/ﬂask)
were cultured in DMEM medium with 10% FBS,
glutamine and antibiotics. EBV-transformed lymphocyte
cell lines derived from normal (GM03657) and AT donors
(GM03189, Coriell Cell Repositories) were cultured at
3–5 10
5 cells/ml in RPMI medium (Sigma) with 15%
FBS, glutamine and antibiotics.
Cells were cultured with 5mM 360A, a concentration at
which we have previously shown that 360A induced a
strong telomere instability (24), or with the corresponding
concentration of DMSO (0.05%) as controls. g-irradiated
cells (IBL637, CisBio International) were collected 1h
after irradiation.
Cell cycle analysis and apoptosis detection
Cell cycle analysis and quantiﬁcation of apoptotic cells
by TUNEL assays were performed as previously
described (24).
Fluorescent in situ hybridization (FISH) and Immuno-FISH
Metaphase spreads were performed as previously
described (29), ﬁxed in 4% formaldehyde and hybridized
with a telomeric Cyanine-3-conjugated (C3AT2)3 peptide
nucleic acid (PNA) probe (Applied Biosystems) com-
plementary to the G-rich telomeric strand using standard
PNA–FISH procedures (30) following by hybridization
with a FITC-pan-centromeric DNA probe (Cambio).
The chromosome preparations were counterstained with
DAPI and observed under a ﬂuorescence microscope
(Olympus IX81). Image acquisition (coolsnap HQ
camera, Princetown instrument) was controlled through
MetaMorph software (Universal Imaging): three gray-
scales 16-bit images [Dapi, Cyanine 3 (telomere probe)
and FITC (centromeres)] with pixel size of 0.13mm were
obtained per metaphase. Then, merging images were
created by false-color image superpositions and
compressed in 8-bit tiﬀ ﬁles. Statistical analyses (t-tests)
were done with StatView software.
For Immuno-FISH, immunostaining of 53BP1 was
performed as described below and followed by incubation
in PBS 0.1% Triton X-100, ﬁxation 5min in 2%
paraformaldehyde (PFA), dehydratation with ethanol
and air dried. Cells were then hybridized with the
telomeric FITC-conjugated (C3AT2)3 PNA probe as
described above. We calculated the percentage of coloca-
lization of 53BP1 and PNA signals using the module of
colocalization of MetaMorph software. 53BP1 was chosen
for these experiments since its detection is easier than
that of ATM and because 53BP1 foci are less diﬀuse than
that of g-H2AX increasing the stringency of the analysis.
Chromosome orientation-FISH (CO-FISH)
CO-FISH allows to diﬀerentiate chromosome lagging
strand telomeres from leading strand telomeres by the
respective detection of parental TTAGGG and CCCTAA
telomere strands after selective degradation of the
neosynthesized strands. CO-FISH was performed as
previously described (31,32) with few modiﬁcations.
Brieﬂy, cells were grown in complete medium containing
BrdU (10mM) for one cell cycle. Metaphase spreads were
performed as described above. Slides were treated with
RNAse (0.5mg/ml), stained with Hoechst 33258, exposed
to UV light and digested with exonuclease III. After
dehydratation, slides were hybridized (2h at RT) with a
telomeric FITC-conjugated (T2AG3)3 PNA probe
(Applied Biosystems) complementary to the C-rich
telomeric strand (leading strand), following by an incu-
bation (2h at RT) with a telomeric Cyanine-3-conjugated
(C3AT2)3 PNA probe complementary to the G-rich
telomeric strand (lagging strand). After washings and
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Figure 1. Cell growth arrest and apoptosis induced by the G-quadruplex ligand 360A in ATM-proﬁcient and deﬁcient immortalized cell lines.
(A) Cell growth curves of ATM
KD and control HeLa cells, normal (GM03657) and AT (GM03189) EBV-lymphocytes, and, normal (AS3WT2) and
AT (GM9607) SV40-ﬁbroblasts treated with 5mM 360A or 0.05% DMSO as controls. 360A induced cell growth arrest following by massive cell
death in all these cell lines. Similar results were obtained at least in three independent experiments. (B) TUNEL labeling of cells treated with 5mM
360A (or 0.05% DMSO) for 8 days (on the left) or for longer times (11 days or 14 days for SV40-ﬁbroblasts) (on the right). Samples were analyzed
by ﬂow cytometry and the proportion of TUNEL-positive cells was expressed as percentage of total population. Data are the means SE of at least
two independent experiments.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1743DAPI counterstained, at least 30 metaphases per
condition were scored.
Immunostaining
The sources of primary antibodies were as follows: mouse
anti-g-H2AX clone JBW301 and mouse anti-ATM
phosphoserine 1981 clone 10H11.E12 (Upstate); rabbit
anti-SMC1 phosphoserine 957 and rabbit anti-53BP1
(Novus Biologicals); rabbit anti-ATM phosphoserine
1981 (Abcam).
After a blocking step (10% FBS in PBS or 3% BSA in
0.1% Triton X-100 TBS, 1h at RT), cells previously ﬁxed
(either in 50% methanol/50% acetone, 1h at –208Co r
95% ethanol/5% acetic acid, 5min at RT or 4% PFA for
10min followed by permeabilization in 0.1% Triton X-100
PBS), cells were incubated with the primary antibody in
blocking buﬀer (1h at RT or overnight at 48C), then
washed and incubated with Alexa-conjugated secondary
antibody (Molecular Probes) for 1h. Cells were counter-
stained with DAPI before observation under a ﬂuores-
cence microscope (Olympus B51). For each condition,
50 to 200 random chosen cells were counted. Statistical
analyses were done with StatView software (Abacus
Concepts).
RESULTS
ATMattenuates 360A-induced telomere instability
We have previously shown that the pyridine derivative
G-quadruplex ligand 360A induced telomere instability
and cell death in various cell lines (24). In order to
evaluate the importance of ATM for telomere main-
tenance, we tested the eﬀects of 360A in stable HeLa cells
expressing siRNA knocking down ATM (ATM
KD HeLa
cells) (27) and control HeLa cells (carrying a pEBV-based
plasmid with an inactive siRNA), which allowed us to
determine the consequences of ATM defect in a same
cellular context. We also treated cell lines derived from AT
patients [ATM-deﬁcient EBV-lymphocyte (GM03189)
and SV40-ﬁbroblast (GM09607) cell lines] and their
respective ATM-proﬁcient controls prepared from
normal donors.
ATM-deﬁcient cells have been shown to be hypersen-
sitive to ionizing radiation and radiomimetic drugs (3).
However, 360A induced decrease in population doublings
followed by apoptotic cell death within 14 days of
treatment in all ATM-deﬁcient and proﬁcient cell lines
as in ATM
KD HeLa cells and controls (Figure 1).
We then analyzed the chromosome aberrations induced
by 360A on metaphase spreads after 8 days of treatment,
thus before induction of signiﬁcant cell death (Figure 1B).
Contrary to genotoxic stresses such as ionizing radiation,
360A neither modiﬁed signiﬁcantly the average numbers
of chromosomes per cell, nor induced chromatid breaks
in the cell lines studied whatever their ATM status (data
not shown and Supplementary Figure 2). However, FISH
with telomeric and centromeric probes on metaphase
spreads showed that 360A induced a strong telomere
instability leading to a broad spectrum of telomere
aberrations with 16.7% 0.9 chromosomes with damaged
telomeres in 360A-treated HeLa cells versus 7.3% 0.4
in untreated controls (t-test P-value <0.0001). Telomere
damages were signiﬁcantly more abundant (t-test
P-value<0.0001) in 360A-treated ATM
KD HeLa cells
with 32.6% 1.8 chromosomes with damaged telomeres
versus 11.6% 1.0 in control cells (Figure 2).
360A induced the formation of dicentric chromosomes
resulting from telomere fusion—as deduced from the
presence of telomeric signals at the fusion points—in
similar range than that reported for other G-quadruplex
ligands (24,33,34). By contrast 360A did not induce the
formation of dicentric chromosomes lacking telomere
sequences at the fusion points suggesting the speciﬁc
involvement of telomere destabilization in chromosome
fusions induced by 360A (Supplementary Figure 3).
Interestingly, we showed that 360A induced more sister
telomere fusions than telomere fusions of two distinct
chromosomes (Figure 2). 360A also induced telomere
aberrations previously described in other models in which
telomeres were destabilized: telomere losses—as shown by
chromosomes lacking telomere signal on one or two
sister chromatids (referred to as one telomere loss and
terminal deletion, respectively)—extrachromosomal
telomere signals—that could not be quantiﬁed
precisely—(35), telomere doublets at single chromatid
ends (13,36) and telomeric DNA-containing double
minute chromosome (TDM) (37) (Figure 2).
Similar results were obtained with EBV-lymphocyte
and SV40 ﬁbroblast cell lines, in which FISH also showed
that 360A increased telomere aberrations in a greater
extent in AT cells compared to ATM-proﬁcient cells
(Supplementary Figure 4).
Consistent with a role of ATM in telomere main-
tenance, we found a signiﬁcant increase in spontaneous
telomere aberrations in ATM-knockdown and ATM-
deﬁcient cell lines compared to their controls with 1.4–2%
more of damaged telomeres in each cell lines studied
(Figure 3). In order to ascertain that ATM has also a role
in the response to 360A, we compared the percentages of
telomere aberrations directly attributable to 360A in each
cell lines that we estimated by subtracting the background
telomere instability—calculated from DMSO controls
(Table 1)—from the percentages of total damaged
telomeres found in 360A-treated cells. Table 1 shows
that ATM defect signiﬁcantly increased (1.8–2.4 times,
t-test P-value  0.0005) telomere damages induced by
360A in the three diﬀerent cellular contexts studied.
Altogether these results conﬁrmed that treatment with
360A induced a massive cell death of immortalized cell
lines after few population doublings associated with
the induction of telomere instability and that ATM
deﬁciency signiﬁcantly increased telomere damages
induced by 360A.
Increases intelomere aberrations in 360A-treated ATM
deficient or knocked-down cellsare not relatedto defectsin
cell cycle checkpoint and apoptosis induction
Induction of cell cycle checkpoints and apoptosis
are generally considered to be essential functions of
ATM signaling following DNA damages (4,8,38).
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before induction of apoptosis in 360A-treated cultures
(Figure 1B), one could speculate that the increase of
telomere rearrangements induced by 360A in cells lacking
functional ATM was the direct consequence of a defect in
cell-cycle checkpoints and apoptosis induction, allowing
cells with damaged telomeres to be analyzed at metaphase,
contrary to cells with functional ATM.
We thus investigated the eﬀects of ATM on cell cycle
progression in 360A-treated cells (Table 2). We found a
S-phase accumulation in ATM-proﬁcient, but not in
ATM-deﬁcient EBV-lymphocytes treated with 360A
before induction of cell death. However, ATM status
did not modify cell cycle distribution in 360A-treated
SV40-ﬁbroblasts and HeLa cells compared to DMSO-
treated controls. This suggests that the lower levels of
telomere aberrations found in metaphases of ATM-
proﬁcient SV40-ﬁbroblasts and HeLa cells were not
due to cell-cycle checkpoint arrest, which would have
prevented the analysis of cells with high levels of damaged
telomeres.
We then analyzed the distribution of telomere
damages in treated cells in function of their ATM status.
If ATM deﬁciency had increased 360A-induced telomere
aberrations because of defects in checkpoints activation
and induction of apoptosis of damaged cells, 360A-treated
cultures of ATM-deﬁcient cells would have contained
a subpopulation of cells with higher percentages of
damaged telomeres corresponding to the cells that had
escaped checkpoints or death due to the lack of functional
ATM. The results (Figure 3) show that this was not the
case. First, 360A increased the percentages of telomere
aberrations in all normal and ATM-deﬁcient cells.
Second, most if not all 360A-treated ATM-deﬁcient cells
have a percentage of damaged telomeres largely higher
than that found in untreated controls and 360A-treated
ATM-proﬁcient cells.
All together our results rule out the hypothesis that the
increase of telomere aberrations found at metaphase in
ATM-deﬁcient cells was simply the consequence of defects
in cell checkpoint activation and apoptosis induction
demonstrating thus that ATM has a more direct
protective role at telomeres.
360A specifically increases sister telomere fusions
inATM
KDHeLa cells, but doesnot induce telomere
sister chromatid exchange (T-SCE)
We next performed CO-FISH on metaphase chromo-
somes from ATM
KD and control HeLa cells treated with
Figure 2. 360A induces speciﬁc telomere aberrations in HeLa cells that are increased in ATM knocked down cells. Histograms show the percentages
of chromosomes with the indicated telomere aberration per cell detected in metaphase spreads of ATM
KD and control HeLa cells treated with 5mM
360A for 8 days (or 0.05% DMSO) and hybridized successively with a telomeric PNA probe (in red) and a centromeric DNA probe (in green) and
then counterstained with DAPI (blue). Percentages SEs were calculated from n=30 metaphases per condition. The mean number of chromosomes
per cell was 66 and remained unchanged in ATM
KD and control HeLa cells.
 Indicates a t-test P-value  0.05;
  P<0.001;
   P<0.0001;
#indicates a
signiﬁcant diﬀerence between DMSO-treated ATM
KD and control HeLa cells. Dicentric chromosomes taken into account contained telomere signals
at the fused points (No dicentric chromosome without telomere signals at the fused points were detected, see Supplementary Figure 3).
Representative images of the diﬀerent telomere aberrations are presented at the bottom.
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leading to telomere instability by determination of the
respective involvements of lagging and leading strand
telomeres in recombination events or losses.
We ﬁrst checked for induction of T-SCE by 360A.
T-SCE occurs at late S phase or G2 between telomeres of
sister chromatids. In this process, the G-overhang of one
telomere invades the other telomere and anneal with
complementary sequences acting asaprimer forshortening
or elongating telomeres when exchanged segments are not
equalextension(1).Althoughnoneofthecelllinesinvolved
in this studyarealternative lengthening oftelomeres (ALT)
cells, in which T-SCE has been shown to occur principally
(39), one could not exclude that T-SCE was induced by the
G-quadruplex ligand. However, results of CO-FISH
demonstrated the lack of exchange between leading and
lagging strand telomeres and thus that 360A did not
signiﬁcantly induce T-SCE in HeLa cells whatever their
ATM status (Supplementary Table 1).
CO-FISH showed that 360A-induced sister chromatid
fusions systematically contained both parental lagging and
leading strands at the fusion point in both control and
ATM
KD Hela cells (Figure 4A). Thus, these results
conﬁrm that 360A-induced sister chromatid fusions
resulted from telomere fusions of sister telomeres—and
not from fusion between telomeres and DNA DSBs
elsewhere on the chromosome—and the speciﬁcity of their
increase found in ATM-deﬁcient cells (Figure 2).
Altogether these data conﬁrm that ATM protects
destabilized sister telomeres from 360A-induced fusions.
ATM reduces telomere lossesand doublets, which result
from lagging strandtelomere dysfunctions induced by 360A
We then analyzed by CO-FISH involvement of lagging
and leading strand telomeres in the formation of telomere
doublets. Telomere doublets are characterized by two
telomere arrays (one in terminal position) separated by
various lengths of nontelomeric DNA on one sister
chromatid, whereas the other keeps a single telomeric
signal in terminal position (Figure 4B). Telomere doublets
have been reported in other studies but mechanisms
leading to their generation remain unknown (13,36). In
both treated and untreated cells whatever their ATM
status, CO-FISH showed that telomere doublets were
mainly made of either two lagging strand telomere
sequences or two leading strand telomere sequences,
whereas the telomeres of the others chromatids were
Table 1. Comparison between percentages of damaged telomeres induced by 360A in metaphase spreads of ATM-deﬁcient cells and in their
respective ATM-proﬁcient controls
Percentage of damaged telomeres
Induced by 360A
c
Background Level
a Due to ATM defect
b ATM-proﬁcient ATM-deﬁcient Ratio t-test P-value
HeLa 2.2 0.1 (n=30) 1.4 0.3 (n=30) 2.7 0.3 (n=30) 6.9 0.5 (n=28) 2.5 < 0.0001
EBV-lymphocytes 3.2 0.4 (n=30) 1.9 0.4 (n=30) 4.0 0.4 (n=30) 9.6 0.9 (n=30) 2.4 < 0.0001
SV40-ﬁbroblasts 4.9 0.2 (n=81) 2.0 0.3 (n=65) 2.2 0.3 (n=55) 3.9 0.4 (n=80) 1.8 0.0005
Ratios were calculated by dividing the values from ATM-deﬁcient cells by those from ATM-proﬁcient cells. The t-test P-values indicate a signiﬁcant
diﬀerence between ATM-deﬁcient and ATM-proﬁcient values.
aPercentages of damaged telomeres   SE found in ATM-proﬁcient DMSO controls calculated from n cells.
bPercentages of damaged telomeres   SE due to ATM deﬁciency in the diﬀerent cell contexts were calculated from percentages of damaged telomeres
found in DMSO-treated ATM-deﬁcient cells minus the mean of damaged telomeres observed in ATM-proﬁcient DMSO controls.
cPercentages of damaged telomeres   SE induced by 360A (5mM for 8 days) in the diﬀerent cell contexts were calculated from n cells minus mean of
percentages damaged telomeres determined in the respective DMSO controls.
Figure 3. The increase of telomere damages concerns all metaphasic
cells in 360A-treated ATM-deﬁcient cell cultures. Analysis of the
distribution of telomere damages in metaphases from ATM
KD and
control HeLa cells, normal (GM03657) and AT (GM03189) EBV-
lymphocytes, and, normal (AS3WT2) and AT (GM09607) SV40-
ﬁbroblasts treated with 5mM 360A or 0.05% DMSO for 8 days.
Box graph shows the distribution of the percentages of damaged
telomeres found in each cell (30 to 80 cells per conditions).
Boxes include 50% of the values centered on the median (the horizontal
line through the box). The vertical lines begin at the 10th percentile and
end at the 90th percentile;
   indicates a t-test P-value <0.0001;
#indicates a signiﬁcant diﬀerence between ATM-proﬁcient and deﬁcient
cells treated with DMSO. Telomere aberrations taken into account
were sister chromatid telomere fusions, one telomere losses, telomere
doublets, TDM and dicentric chromosomes with telomere signals at
fusion points. Terminal deletions were excluded from these analyses
since they could also arise from double-strand breaks, although this
had no impact on the ﬁnal results (data not shown).
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This observation indicates that mechanisms of generation
of telomere doublets involved in most cases neither
duplication of telomere sequences—no telomere doublets
would have been detected by CO-FISH, since the protocol
involved a degradation of duplicated DNA before
hybridization—nor sister chromatid exchange—the telo-
mere doublets detectable by CO-FISH would have been
made with both lagging and leading telomeres.
Interestingly, we found that telomere doublets induced
by the G-quadruplex ligand mainly involved the lagging
strand telomeres (Figure 4B).
Importantly, CO-FISH also showed (Figure 4B) a
signiﬁcant increase (Chi-square P-value <0.001) in the
proportion of telomere doublets made of lagging strand
sequences in 360A-treated ATM
KD Hela cells (90%)
compared to 360-treated controls (79%). This suggests
therefore that the increase in telomere doublets evidenced
in 360A-treated ATM knockdown cells (Figure 2)
involved preferentially the lagging strand telomeres,
indicating thus that ATM speciﬁcally protects the lagging
strand telomeres from 360A-induced formation of telo-
mere doublets.
We next investigated the chromosomes missing one
telomere. CO-FISH demonstrated an increase in the
proportion of telomere loss involving the lagging-strand
telomere in 360A-treated cells (Figure 4C). This was not
due to a weaker sensitivity of the C-probe or competition
with the G-quadruplex ligand, since in the same experi-
ments most of extrachromosomal telomere signals (data
not shown) and telomere doublets (as shown above) were
found to involve the lagging and not the leading strand
telomeres. This result indicates that the increase in
telomere loss found in 360A-treated cells (Figure 2)
resulted from the preferential deletion of the lagging
strand telomeres. This demonstrates thus that the mechan-
ism of telomere loss induced by 360A involved speciﬁc
telomere impairment and was not due to an unrelated
cause such as DSBs occurring upstream telomeres.
Moreover, as for telomere doublets, CO-FISH showed
a signiﬁcant increase (Chi-square P-value <0.001) in the
proportion loss of the lagging strand telomeres in 360A-
treated ATM
KD cells (85%) compared to 360A-treated
HeLa controls (63%) (Figure 4C). Altogether, our results
suggest therefore that the compound speciﬁcally induced
recombination of the lagging strand telomeres resulting
either in telomere doublet or telomere loss and that
ATM speciﬁcally prevents these mechanisms to occur.
Interestingly, CO-FISH also showed that a signiﬁcant
increase (Chi-square P-value <0.001) in the proportion of
telomere loss concerning the lagging strand telomeres in
untreated ATM
KD HeLa cells (72%) compared to control
HeLa cells (52%) (Figure 4C). This indicates therefore
that the increase in telomere loss evidenced in untreated
ATM
KD cells (Figure 2C) involved preferentially the
lagging strand telomeres, which signiﬁcance for ATM
putative roles at telomeres during unperturbed replication
remains to be further investigated.
The G-quadruplexligand 360A induces aDNA
damage signaling inastrictly ATM-dependent manner
In order to further investigate the role of ATM in response
to 360A, we then studied ATM signaling in Hela cells.
We found that 360A signiﬁcantly increased nuclear foci
of activated ATM by performing immunoﬂuorescence
staining with an antibody against its phosphorylated form
(serine 1981) (Figure 5A and B). These foci colocalized
with that of phosphorylated H2AX, a member of the
nucleosome core histone H2A family, which is phos-
phorylated on serine 139 (referred to as g-H2AX) mainly
by ATM, at chromatin adjacent to DNA DSBs (40) and
at dysfunctional telomeres (10,41). 360A induced a
signiﬁcant increase in the number of g-H2AX nuclear
foci in HeLa cells compared to DMSO controls
(Figure 5A and B). 360A also induced the formation of
nuclear foci of 53BP1 and of the phosphorylated forms
of SMC1, which for the most colocalized with that of
Table 2. Cell-cycle distribution of ATM-deﬁcient cells and their respective ATM-proﬁcient controls treated for 7–8 days with 5mM 360A or
0.05% DMSO.
Cell line ATM status Treatment Cell-cycle distribution (%)
a  
2p-values
b
G1 S G2/M
HeLa Control 0.05% DMSO 57.3 0.1 32.6 0.5 10.1 0.4 ns
5mM 360A 57.9 2.1 32.6 2.4 9.5 0.3
ATM
KD 0.05% DMSO 65.6 3.2 26.7 2.5 7.7 0.7 ns
5mM 360A 61.9 0.5 28.3 0.3 9.8 0.8
EBV-lymphocytes Normal 0.05% DMSO 48.8 4.0 43.5 3.5 7.7 0.5 0.017
5mM 360A 30.4 0.7 63.3 0.6 6.3 1.3
AT 0.05% DMSO 62.5 1.4 26 1.4 11.5 2.8 ns
5mM 360A 69.9 0.6 18.8 0.9 11.3 0.3
SV40-ﬁbroblasts Normal 0.05% DMSO 49.7 4.8 33.9 3.4 16.4 1.4 ns
5mM 360A 44.6 3.5 36.4 1.7 19 1.7
AT 0.05% DMSO 36.3 4.3 40.3 2.4 23.4 6.8 ns
5mM 360A 41.2 8.6 37.8 3.7 21 4.9
aPercentages of cells in diﬀerent phases of the cell cycle are expressed with respect to the total number of viable cells. Means and standard deviations
of two independent experiments are shown.
bFor each cell line, the cell cycle distribution of 360A-treated cells was compared with that of DMSO controls by performing chi-square ( 
2) analysis
on mean values. ns: non signiﬁcant.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1747Figure 4. Respective involvement of lagging and leading telomeres in telomere aberrations induced by 360A revealed by CO-FISH in ATM
KD
and control HeLa cells. CO-FISH was performed on metaphases of ATM
KD and control HeLa cells treated with 5mM 360A for 8 days (or 0.05%
DMSO). Lagging strand telomeres are labeled in red and leading strand telomeres in green. (A) Example of CO-FISH analysis from metaphase
spreads of HeLa cells treated with 360A for 8 days showing that sister chromatid fusions involved telomeres of the two chromatids (white arrows
and enlarged views) and not telomere-DNA double-strand break fusions. (B) Respective percentages of telomere doublets containing two lagging
strand telomeres (G-G doublets) or two leading strand telomeres (C-C doublets) or both lagging and leading strand telomeres (others doublets)
in ATM
KD and control HeLa cells. n=total number of telomere doublets analyzed. Examples of telomere doublets are shown on the left. Chi-square
analysis was performed to detect diﬀerences in the repartition of telomere doublets containing two G-G, two C-C or other doublets between
the diﬀerent conditions (
  P<0.001). (C) Percentages of single telomere loss aﬀecting the lagging or the leading strand in ATM
KD and control
HeLa cells. n=total number of telomere loss analyzed. Examples of missing lagging or leading strand telomeres are shown on the left. Chi-square
analysis was performed to detect diﬀerences in the repartition of missing lagging or leading strand telomeres between the diﬀerent
conditions (
 P<0.05;
  P<0.001).
1748 Nucleic Acids Research, 2008, Vol. 36, No. 5g-H2AX (Figure 5A and C), consistently with the well-
known role of g-H2AX in the recruitment of DNA repair
and checkpoint proteins at DNA damage sites (42).
We then investigated the localization of these DNA
damage foci by immunostaining of 53BP1 followed by
hybridization with a telomere-speciﬁc ﬂuorescent PNA
probe (Figure 5D and E). Colocalization of 53BP1
with PNA signals signiﬁcantly increased 14 times in
360A-treated cells in comparison to DMSO controls
(8.3% versus 0.6%; Figure 5D and E). Since we found
only around 5% of colocalization in 2Gy-irradiated
HeLa cells that had three times more 53BP1 foci than
360A-treated cells (Figure 5F), increase in overlapping
between 53BP1 and PNA signals in 360A-treated cells
cannot be the simple consequence of increased area of
53BP1 foci. Therefore, our results indicate that 360A
induced a DNA damage signaling at telomeres similar
to telomere dysfunction-induced foci (TIFs) (10,43).
Figure 5. 360A induces DNA damage signaling. (A–C) 53BP1 and phosphorylated forms (P-) of ATM and SMC1 form foci that co-localized with
g-H2AX following 360A treatment in HeLa cells. HeLa cells were treated with 5mM 360A (or 0.05% DMSO as control) for 7 days, ﬁxed and
costained with anti-g-H2AX and speciﬁc antibodies of 53BP1, P-ATM and P-SMC1. Typical images of 360A-treated HeLa cells exhibited
colocalizations between foci of g-H2AX and DNA repair factors are shown in (A). Histograms (B) show the numbers of P-ATM, g-H2AX foci and
of their colocalization per cell calculated from at least 50 randomly chosen cells for each condition SE (
   indicate a t-test P-value <0.0001 and
  P<0.005). (C) Colocalizations were quantiﬁed by scoring the number of 53BP1 and P-SMC1 foci colocalized or not with g-H2AX foci in at least
50 randomly chosen cells per condition (
   P<0.0001 and
  P<0.005). (D–F) Colocalization of telomeric-PNA signals (green, in D) and 53BP1 foci
(red, in D) in HeLa cells treated with 5mM 360A (or 0.05% DMSO) for 7 days or exposed to 2Gy-irradiation (IR) and collected 1h after irradiation.
(D) Colocalization was appreciated on merge images shown on the left for the three conditions. Each image was obtained from a maximum
projection of a Z-stack of 15 images, which were previously subjected to 2D deconvolution using the Metamorph software (Universal imaging corp.).
Nuclei stained with DAPI (blue) and enlarged views of colocalized foci from the merged image are shown on the right. Percentage of 53BP1 signal
colocalized with telomeric PNA signal (E) and percentages of nucleus surfaces occupied by 53BP1 foci (F) in the diﬀerent conditions were calculated
with colocalization module of the Metamorph software (
  P<0.001;
   P<0.0001).
Nucleic Acids Research, 2008, Vol. 36, No. 5 1749However, we showed that most of 53BP1 signals did not
colocalize with that of PNA in 360A-treated cells.
This could indicate that 360A induced other DNA
damages at interstitial sites. Alternatively, some
360A-induced DNA damage foci may be localized at
chromosome ends lacking telomeric repeats as suggested
above by the elevated frequencies of telomere loss
evidenced by FISH analysis in 360A-treated cultures.
Interestingly, 360A induced g-H2AX, 53BP1 and SMC1
nuclear foci in ATM-proﬁcient controls, but not in
ATM-deﬁcient cell lines and ATM
KD HeLa cells
(Figure 6). We veriﬁed that ionizing radiation induced
the formation of g-H2AX foci in ATM-deﬁcient cells
(Figure 6A and data not shown) indicating, as previously
shown (42), that radio-induced DNA damages trigger
H2AX phosphorylation in ATM-deﬁcient cells through
alternative pathways, for example involving the ATR
kinase. Therefore, the lack of induction of g-H2AX foci
in 360A-treated ATM-deﬁcient cells indicates the pre-
dominant role of ATM in the signaling of the DNA
damages induced by the G-quadruplex ligand emphasizing
their speciﬁcity compared to DSB-inducing treatments
such as ionizing radiation that are able to activate
g-H2AX foci by alternative pathways involving ATR or
DNA-PK (44,45).
DISCUSSION
We showed here that loss of ATM function sensitized
immortalized cell lines to a broad spectrum of telomere
aberrations speciﬁcally induced by the G-quadruplex
ligand 360A. The increase in telomere instability that we
observed in 360A-treated ATM-deﬁcient cells was not
related to defect in cell cycle checkpoint or apoptosis
induction but evidenced a direct role for ATM in
preventing inappropriate DNA repair at dysfunctional
telomeres.
360A induces abroadspectrum ofspecific
telomere aberrations
The G-quadruplex ligand induced dicentric chromosomes,
which are due to chromosome fusions in G1 or early S
phases. We showed that these dicentric chromosomes
speciﬁcally involved telomere fusions suggesting that
they resulted from NHEJ (nonhomologous end joining)
activation at dysfunctional telomeres (46) (Figure 7A).
We also showed that 360A induced many telomere
aberrations that have not been reported to date for
other G-quadruplex ligands. This is the case of TDM that
we found particularly in 360A-treated ATM-deﬁcient
cells. TDM have been proposed to result from
Figure 6. ATM is required for 360A-induced DNA damage signaling. (A) Percentage of cells with g-H2AX foci in normal (GM03657) and AT
(GM03189) EBV-lymphocyte cell lines treated with 5mM 360A or 0.05% DMSO for 7 days or exposed to 5-Gy IR as positive controls, then ﬁxed
and stained with anti- g-H2AX antibodies (
   P<0.0001, n>100). (B, C) Number of g-H2AX foci per cell in normal (AS3WT2) and AT (GM09607)
SV40-ﬁbroblasts (B) and in ATM
KD and control HeLa cells (C) treated as described in (A) (
  P<0.001;
   P<0.0001; n 50). (D) Number of 53BP1
foci per cell in normal (AS3WT2) and AT (GM09607) SV40-ﬁbroblasts treated as described in (A) (
   P<0.0001, n=50). (E) Percentage of cells
with phospho-SMC1 foci in normal (GM03657) and AT (GM03189) EBV-lymphocytes treated as described in (A) and immunostained with anti-
phospho-SMC1 antibodies (
   P=0.0002, n>100).
1750 Nucleic Acids Research, 2008, Vol. 36, No. 5Figure 7. Model for 360A-induced telomere aberrations and the role of ATM in telomere stability. (A) 360A destabilizes telomere T-loops in G1 or
early S by inducing or stabilizing G-quadruplexes at G-overhangs leading either to overhang degradation, or to inappropriate strand-invasion into
interstitial telomere-related sequences in cis forming a large T-loop. In the ﬁrst case, blunt-ended telomeres of distinct chromosomes can be fused by
NHEJ, forming characteristic dicentric chromosomes at metaphase containing parental telomere strands at the fusion points (in yellow) (46). In the
second case, which could be favored by 360A-induced G-quaduplexes at interstitial sites, recombination between telomere and interstitial sequences
generates at metaphase a terminally deleted chromosome and a TDM corresponding to the large T-loop (37). (B) G-quadruplex formation at parental
G-overhang prevents formation of a stable and protected telomere structure in late S and G2. This could lead either to overhang degradation,
unstable T-loop formation or inappropriate overhang-invasion into interstitial sequences in cis. In the ﬁrst case, blunt-ended telomere of the lagging
strand can be fused by NHEJ with sister chromatid before generation of the leading strand G-overhang (alternatively leading strand telomere
G-overhang could be degraded as a consequence of G-quadruplex formation) producing a metaphase chromosome with telomere sister fusion (in
yellow). In the second case, unstable T-loop could undergo T-loop HR (47), which would result at metaphase in a chromosome lacking its lagging
strand telomere and an extra chromosome signal containing parental telomere G-strands (in red). In the third case, recombination between lagging
strand chromosomes and interstitial sequences in cis produces telomere doublets made of two signals of the parental G strand (in red) separated by
interstitial DNA sequences, although the precise mechanism involved is unknown. ATM could attenuate telomere instability by insuring the
reformation of stable and protected structures at destabilized telomeres and after replication through its participation in the process of generation of
T-loop structures. Parental G strands are in red, parental C strands in green and neosynthesized strands in black. Centromeres are represented as
black ellipses.
Nucleic Acids Research, 2008, Vol. 36, No. 5 1751homologous recombination (HR) between a dysfunctional
telomere and interstitial DNA in cis forming a large
T-loop containing nontelomeric DNA arrays (37).
Subsequent cleavages, followed by replication, result in a
TDM, a circular product containing two telomere signals
(but no centromeric sequence) corresponding to the large
T-loop and a terminally deleted chromosome lacking
telomeres (37) (Figure 7A). At least some of the terminally
deleted chromosomes found in treated cells may have
thus been generated as a consequence of telomere
destabilization.
Detection of both dicentric chromosomes and TDM
indicates that 360A can destabilize telomeres in G1 or
early S. But, one important ﬁnding of this study is that
360A mainly induced telomere aberrations that occurred
during or after telomere replication (i.e. sister chromatid
telomere fusions, loss of one telomere and telomere
doublets), which highly suggests that 360A impedes
reformation of a protected structure at telomeres at this
step of the cell cycle.
Sister chromatid telomere fusions have been shown
to be due to NHEJ (46) (Figure 7B). Their increase in
360A-treated cells suggests that 360A can act at both the
lagging and the leading strand telomeres. However, one
other important ﬁnding of the present study is the
demonstration that the lagging strand telomeres were
more frequently lost or involved in telomere doublets than
the leading strand telomeres, particularly in 360A-treated
ATM-deﬁcient cells. This demonstrates that these types
of recombination resulted from a speciﬁc telomere
targeting by the compound. Metaphasic chromosomes
lacking one telomere may have been generated by a
process known as T-loop HR (47), in which the T-loop
becomes a substrate for Holliday junction resolvases
resulting in the deletion of a T-loop-sized segment
(Figure 7B). This is consistent with the detection of
extrachromosomal telomere signals formed principally
with lagging strand telomeres in 360A-treated cells.
Telomere doublets have been previously described in
ATM-deﬁcient mouse cell lines (13) and at low frequency
in human cells (13,48). We demonstrated that their
formation in 360A-treated cells involved, for most of
them, only one chromatid, but no chromatid exchange
and no further sequence duplication. Telomere doublets
induced by the G-quadruplex ligand appear thus to
originate principally from recombination between lagging
strand telomeres and nontelomeric sequences in cis.W e
therefore propose that they derived from improper T-loop
formation as proposed above for TDM, although the
exact mechanisms remain to be elucidated (Figure 7B).
Moreover, preferential involvement of the lagging
strand telomeres in 360A-induced recombination indica-
tes the preferential targeting by the compound of the
parental telomere G-strands (allowing the replication of
the lagging strand telomeres), which is consistent with
the putative mode of action of 360A through
G-quadruplex formation and/or stabilization suggested
by its high in vitro speciﬁcity and aﬃnity for these
structures (24,25). Furthermore, all the types of telomere
recombination induced by 360A that we described here are
also in agreement with the targeting by 360A of the
G-overhang preventing the formation of a stable T-loop,
as proposed previously from in vitro binding assay on
genomic DNA (25). Lower involvement of the newly
synthesized G-strands (of the leading telomere) in
recombinations may reﬂect lower accessibility to the
compound of their G-overhangs, which contrary to that
of the lagging strands absolutely require the action of a
50–30 exonuclease to be generated (49,50).
We showed that 360A triggered DNA damage signaling
outside telomeres that could be indicative of the formation
of G-quadruplex structures at interstitial sites, as pro-
posed previously (25,51). This is sustained by the need of
functional ATM for this signaling to occur indicating
the particularity of these DNA damages. The question of
the importance of these interstitial DNA damages for the
cellular eﬀects induced by 360A remained asked.
However, the telomere targeting by the G-quadruplex
ligand is probably the main cause of cell death, since:
(i) we did not detect by the methods used a signiﬁcant level
of genetic instability that did not involve telomeres in
ATM-proﬁcient, as well as in ATM-deﬁcient cell lines,
and (ii) the strong level of telomere instability and the
frequent detection of anaphase bridges [data not shown;
(24)] observed in treated cells are well consistent with
the induction of mitotic catastrophe after few rounds of
replication. This is further sustained by the rarity
of duplicated telomere doublets on sister chromatids,
conﬁrming that the cells did not enter a second cycle
of division after induction of telomere recombination
regardless their ATM status. However, participation of
interstitial DNA damages in telomere recombination
could not be excluded. This is suggested particularly
in case of TDM and telomere doublets, which are likely
due to telomere recombination in cis with interstitial
sequences as proposed above.
ATM preventsactivation of inappropriate DNA repair
at 360A-induced dysfunctional telomeres
We showed that ATM defect signiﬁcantly and speciﬁcally
increased telomere aberrations induced by 360A in three
diﬀerent cell contexts and that this was not related
to impaired cell cycle checkpoints and apoptosis induc-
tion suggesting that ATM has a more direct role to
protect telomeres. We showed that most of telomere
aberrations induced by 360A, and signiﬁcantly increased
in ATM-deﬁcient cells, resulted from the lack (telomere
sister fusion), improper (telomere doublets) or unstable
(single-strand telomere loss) formation of protected
telomere structures during or after replication
(Figure 7B). ATM has been shown to be recruited at
telomere at every G2-M phase of the cell cycle and
proposed to be needed for recruiting the HR machinery,
which could promote T-loop formation (16,17). Our
results give thus another indication that ATM has a role
at telomeres at this step of the cell cycle, which supports
the hypothesis that ATM participates to the formation
of a stable and protected telomere structure. ATM could
thus reduce telomere aberrations in 360A-treated cells
by allowing the correct formation of a stable T-loop
at destabilized telomeres preventing thus activation
1752 Nucleic Acids Research, 2008, Vol. 36, No. 5of inappropriate DNA repair. Increases in dicentric
chromosomes and TDM in 360A-treated ATM-deﬁcient
cells suggest that ATM may be also needed to reform a
protected structure at telomeres destabilized by 360A
at earlier phase of the cell cycle (Figure 7A).
Importantly, we found that 360A induced the formation
of TIFs, similar—but at reduced quantitative levels—to
that caused by telomere deprotection at cell senescence or
resulting from TRF2 inhibition (10,43), which roles are
still not clearly deﬁned. The lack of TIF in ATM-deﬁcient
cells treated by 360A clearly demonstrates that TIFs
are dispensable or not involved in the activation by the
G-quadruplex-ligand of inappropriate DNA repair at
dysfunctional telomeres. Rather, they may be directly
involved in the protective role of ATM at telomeres.
To conclude, we showed that the G-quadruplex ligand
360A induced a large spectrum of speciﬁc telomere
damages probably through the induction and/or stabiliza-
tion of G-quadruplex at telomere overhangs preventing
correct reformation of a stable T-loop structure. ATM
appears to have a direct protective role against activation
of inappropriate DNA repair mechanisms at dysfunc-
tional telomeres, distinct from its roles in checkpoint
activation and apoptosis induction, and which could be
related to its possible participation in the process of
T-loop formation.
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